Guangdong Provincial People's Hospital: clinical-trial pipeline
Guangdong Provincial People's Hospital is the sponsor of 237 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 93 are not yet finished and 1 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 153 |
| Phase 2 | 40 |
| Phase 4 | 19 |
| Phase 3 | 12 |
| Phase 2/3 | 5 |
| Phase 1 | 4 |
| Phase 1/2 | 3 |
| Early phase 1 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 98 |
| Recruiting | 51 |
| Completed | 42 |
| Not yet recruiting | 28 |
| Active, not recruiting | 14 |
| Terminated | 2 |
| Withdrawn or not authorised | 2 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 101 |
| Cardiovascular | 57 |
| Nephrology and urology | 40 |
| Metabolic and endocrine (diabetes, obesity) | 21 |
| Respiratory | 16 |
| Gastroenterology and liver | 11 |
| Neurology | 9 |
| Rare and genetic diseases | 7 |
| Infectious disease and vaccines | 6 |
| Psychiatry and mental health | 6 |
| Musculoskeletal | 5 |
| Haematology | 2 |
Countries
| Country | Trials |
|---|---|
| China | 209 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-25 | New trial posted | Local Consolidative Therapy Versus Maintenance Immunotherapy After First-Line Chemoimmuno… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06547476 | Chidamide and PD-1 Inhibitor Plus Anlotinib for HER2-low Breast Cancer That Has Spread or Cannot be Surgicall… | Phase 2 | Not yet recruiting | |
| NCT06506838 | Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma | Phase 4 | Recruiting | China |
| NCT05616416 | International Big Data Centre in Emergency Medicine | Not applicable | Recruiting | China |
| NCT06533384 | PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC | Phase 3 | Recruiting | China |
| NCT04212455 | A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study) | Not applicable | Recruiting | China |
| NCT07738328 | Terbinafine for CSA-AKI Prevention | Phase 2 | Not yet recruiting | China |
| NCT07752589 | Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLC | Not applicable | Not yet recruiting | China |
| NCT07098351 | Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritonea… | Not applicable | Recruiting | China |
| NCT04212468 | Home Blood Pressure Monitoring Registration Study in the Elderly(HOME Study) | Not applicable | Recruiting | China |
| NCT05281887 | Correlation Between the Changes of Retinal Structure and Function and Ischemic Stroke | Not applicable | Recruiting | China |
| NCT07686796 | Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy… | Phase 3 | Not yet recruiting | China |
| NCT06498050 | Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Ed… | Phase 4 | Active, not recruiting | China |
| NCT06300424 | Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC | Phase 2 | Active, not recruiting | China |
| NCT07746453 | Universal STAR-T Cell Injection in Autoimmune Kidney Diseases | Not applicable | Not yet recruiting | China |
| NCT06979115 | Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Rese… | Not applicable | Not yet recruiting | China |
| NCT07604805 | Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension | Not applicable | Recruiting | China |
| NCT07170046 | Predictive Value of CEA and ctDNA in Lung Cancer Recurrence | Not applicable | Not yet recruiting | |
| NCT05740943 | Induction Lorlatinib in Stage III Non-small Cell Lung Cancer | Phase 2 | Active, not recruiting | China |
| NCT06071234 | Preoperative Evaluation of 3D Reconstruction Tool for Nipple-sparing Mastectomy | Not applicable | Active, not recruiting | China |
| NCT07727122 | Multicenter Prospective Validation of AI Models for Malignancy Risk Prediction in Pulmonary Nodules | Not applicable | Not yet recruiting | China |
| NCT07136792 | A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxi… | Not applicable | Recruiting | China |
| NCT07352930 | A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for… | Not applicable | Recruiting | China |
| NCT05188885 | A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases | Not applicable | Recruiting | China |
| NCT06911606 | Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SC… | Phase 2 | Recruiting | China |
| NCT04946734 | Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine | Phase 3 | Active, not recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Guangdong Provincial People's Hospital clinical trials: 93 open, 17 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/guangdong-provincial-people-s-hospital/, data as of 2026-10-25.